Follow the 셀로맥스사이언스 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 셀로맥스사이언스 has recorded 15 public disclosures. Market capitalisation: €52.1bn. The latest transaction was disclosed on 7 April 2026 (Purchase). Among the most active insiders: 서정민. All data is accessible without an account.
15
Insider Decl.
0
Thresholds
·
7 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,000 of 26,270 companies
65.2
score / 100
Value
58
Quality
72
FCF yld3.3%
Earn yld6.1%
EV/EBITDA12.3x
ROE7.6%
Gross mgn48%
Net mgn13%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.